Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Clark

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Expert Opinion on Investigational Drugs|April 1, 1997
The therapeutic potential of anti-cytokine strategies in central nervous system ischaemiaW M Clark, H L Lutsep
Drugs in R&D|November 24, 1999
Neuroprotection in acute ischaemic stroke. Current status and future potentialH L Lutsep, W M Clark
The Medical Clinics of North America|January 1, 1993
Abnormalities of hemostasis in ischemic strokeB M Coull, W M Clark
Federation Proceedings|October 29, 2010
Symposium on biochemistry of malarial parasitesW M CLARK, E A EVANS
Neuroimaging Clinics of North America|August 5, 1999
Medical treatment strategies: intravenous thrombolysis, neuronal protection, and anti-reperfusion injury agentsW M Clark, H L Lutsep
Clinical Science|March 19, 2010
Anergy in infants' skin to diphtheria toxinG P WRIGHT, W M CLARK
Journal of the Tennessee Medical Association|January 1, 1988
Listeria monocytogenes endocarditisR T Jackson, W M Clark
Neurology|November 26, 1997
Antileukocyte adhesion therapy: preclinical trials and combination therapyW M Clark, J A Zivin
Neurology|September 12, 2000
Association of intracranial stenosis with cortical symptoms or signsH L Lutsep, W M Clark
Current Neurology and Neuroscience Reports|March 20, 2002
Current status of neuroprotective agents in the treatment of acute ischemic strokeH L Lutsep, W M Clark
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Expert Opinion on Investigational Drugs|April 1, 1997
The therapeutic potential of anti-cytokine strategies in central nervous system ischaemiaW M Clark, H L Lutsep
Drugs in R&D|November 24, 1999
Neuroprotection in acute ischaemic stroke. Current status and future potentialH L Lutsep, W M Clark
The Medical Clinics of North America|January 1, 1993
Abnormalities of hemostasis in ischemic strokeB M Coull, W M Clark
Federation Proceedings|October 29, 2010
Symposium on biochemistry of malarial parasitesW M CLARK, E A EVANS
Neuroimaging Clinics of North America|August 5, 1999
Medical treatment strategies: intravenous thrombolysis, neuronal protection, and anti-reperfusion injury agentsW M Clark, H L Lutsep
Clinical Science|March 19, 2010
Anergy in infants' skin to diphtheria toxinG P WRIGHT, W M CLARK
Journal of the Tennessee Medical Association|January 1, 1988
Listeria monocytogenes endocarditisR T Jackson, W M Clark
Neurology|November 26, 1997
Antileukocyte adhesion therapy: preclinical trials and combination therapyW M Clark, J A Zivin
Neurology|September 12, 2000
Association of intracranial stenosis with cortical symptoms or signsH L Lutsep, W M Clark
Current Neurology and Neuroscience Reports|March 20, 2002
Current status of neuroprotective agents in the treatment of acute ischemic strokeH L Lutsep, W M Clark
Pageof 10